Quick Search

 

 


 

 

Home > Result Summaries: Compounds > Human Papillomavirus Types 16 and 18 Vaccine > Result Summary for 107336

Result Summary for 107336

Result Summary
Protocol ID: 107336
Clinical Study ID: 107336
Official Title: Safety and immunogenicity study of the HPV vaccine (GSK-580299) in healthy, Chinese, female subjects
Phase: phase 1
Study Indications or Diseases:
  • Infections, Papillomavirus
Generic Name: Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name: Cervarix
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Zhu FC et al. (2011) Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial. Chin J Cancer. 30(8):559-564.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.